Personal information

No personal information available

Activities

Works (12)

A long march for targeted protein degradation in the new era: expanding E3 ligases

Future Medicinal Chemistry
2024-11 | Journal article
Contributors: Dazhao Mi; Anxin Huang; Jingfeng Song; Yihua Chen
Source: check_circle
Crossref

Discovery of novel BCL6-Targeting PROTACs with effective antitumor activities against DLBCL in vitro and in vivo

European Journal of Medicinal Chemistry
2024-11 | Journal article
Part of ISSN: 0223-5234
Contributors: Dazhao Mi; Cheng Li; Yuzhan Li; Mingyue Yao; Yan Li; Keyu Hong; Chengying Xie; Yihua Chen
Source: Self-asserted source
Dazhao Mi

Discovery of a Highly Potent and Selective MYOF Inhibitor with Improved Water Solubility for the Treatment of Gastric Cancer

Journal of Medicinal Chemistry
2023-12-28 | Journal article
Contributors: Haijun Gu; Ting Zhang; Tian Guan; Min Wu; Shen Li; Yunqi Li; Mengmeng Guo; Lin Zhang; Yangrui Peng; Dazhao Mi et al.
Source: check_circle
Crossref

Current advances of small molecule E3 ligands for proteolysis-targeting chimeras design

European Journal of Medicinal Chemistry
2023-08 | Journal article
Contributors: Dazhao Mi; Yuzhan Li; Haijun Gu; Yan Li; Yihua Chen
Source: check_circle
Crossref

Discovery of Pyrimidinediamine Derivatives as Potent Methuosis Inducers for the Treatment of Triple-Negative Breast Cancer

Journal of Medicinal Chemistry
2023-06-08 | Journal article
Contributors: Jia He; Luzhen Wang; DaZhao Mi; Tian Guan; Wenjing Liu; Peng He; Haijun Gu; Yuzhan Li; Yangrui Peng; Ai-Qun Jia et al.
Source: check_circle
Crossref

Discovery of YH677 as a cancer stemness inhibitor that suppresses triple-negative breast cancer growth and metastasis by regulating the TGFβ signaling pathway

Cancer Letters
2023-04 | Journal article
Contributors: Yuzhu Zhang; Jing Chen; Dazhao Mi; Jun Ling; Huachao Li; Peng He; Ning Liu; Qianjun Chen; Yihua Chen; Luqi Huang
Source: check_circle
Crossref

A novel methuosis inducer DZ-514 possesses antitumor activity via activation of ROS-MKK4-p38 axis in triple negative breast cancer.

Cancer letters
2023-01-03 | Journal article
Contributors: Wang L; Mi D; Hu J; Liu W; Zhang Y; Wang C; Chen Y; Chen C
Source: Self-asserted source
Dazhao Mi

B-cell Lymphoma 6 Inhibitors: Current Advances and Prospects of Drug Development for Diffuse Large B-cell Lymphomas.

Journal of medicinal chemistry
2022-11-28 | Journal article | Author
Contributors: haijun Gu; He J; Li Y; Dazhao Mi; Guan T; Weikai Guo; Liu B; Yihua Chen
Source: Self-asserted source
Dazhao Mi
grade
Preferred source (of 2)‎

An instructive attempt on developing aptamer-constructed PROTAC for breast cancer treatment.

Molecular therapy. Nucleic acids
2022-11-05 | Journal article
Contributors: Zhang Y; Mi D; Yihua Chen
Source: Self-asserted source
Dazhao Mi

Small-Molecule Modulators Targeting SHP2 for Cancer Therapy.

Anti-cancer agents in medicinal chemistry
2022-09-21 | Journal article
Contributors: Mi D; Li Y; Yihua Chen
Source: Self-asserted source
Dazhao Mi

In vivo target protein degradation induced by PROTACs based on E3 ligase DCAF15.

Signal transduction and targeted therapy
2020-07-27 | Journal article
Contributors: Li L; Mi D; Pei H; Duan Q; Wang X; Zhou W; Jin J; Dali Li; Liu M; Yihua Chen
Source: Self-asserted source
Dazhao Mi

Modification and Biological Evaluation of a Series of 1,5-Diaryl-1,2,4-triazole Compounds as Novel Agents against Pancreatic Cancer Metastasis through Targeting Myoferlin

Journal of Medicinal Chemistry
2019-05-23 | Journal article
Contributors: Yunqi Li; Yuan He; Ting Shao; Haixiang Pei; Weikai Guo; Dazhao Mi; Isabelle Krimm; Yuanjin Zhang; Peili Wang; Xin Wang et al.
Source: check_circle
Crossref